Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 28, 2026
TickeronGET DAILY SIGNALS
Cypherpunk Technologies (CYPH) Builds Its Zcash Position Through Treasury and Mining

Cypherpunk Technologies (CYPH) Builds Its Zcash Position Through Treasury and Mining

Key Takeaways

  • Cypherpunk Technologies (CYPH) is a Nasdaq-listed privacy technology company whose strategy is anchored by Zcash (ZEC), a privacy-focused digital asset, alongside a legacy oncology drug-development subsidiary.
  • The company has reported holding roughly 323,394 ZEC, or about 1.92% of circulating supply, positioning it as the largest corporate holder of the token.
  • Shares traded near $3.14 in late October 2026, toward the middle of a 52-week range of approximately $0.39 to $4.19, with a market capitalization near $338 million.
  • The stock was roughly 5% lower over the trailing 30 days, reflecting volatility closely tied to ZEC prices and broader digital-asset sentiment.
  • In August 2026 the company launched Cypherpunk Mining, deploying about 4.2 GSol/s of hashrate — roughly 18% of the Zcash network — through a $33.33 million equity-based transaction backed by Winklevoss Capital.
  • Cantor Fitzgerald raised its price target to $4.90 while maintaining an Overweight rating, though Nasdaq listing compliance remains a key overhang.

Market Snapshot at the End of October 2026

Cypherpunk Technologies closed near $3.14 in late October 2026, finishing the most recent session roughly 10.8% higher versus the prior close of about $2.83. The advance underscores the stock's characteristically high volatility: shares have swung between roughly $2.50 and $4.19 over recent weeks, with daily moves frequently exceeding 10% in either direction. Over the trailing 30 days, the share price was about 5% lower, a modest pullback relative to the outsized rally that lifted the stock from sub-$1 levels earlier in 2026.

The company's market capitalization sat near $338 million on approximately 107.8 million shares outstanding. Because CYPH is fundamentally a digital-asset treasury vehicle, its share price tends to track the value of Zcash with an added premium or discount tied to sentiment around privacy coins, mining economics, and the company's own execution. This structure makes the stock more sensitive to crypto-market conditions than to traditional equity fundamentals. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Business Overview and Competitive Position

Cypherpunk Technologies Inc. is a privacy technology company formerly known as Leap Therapeutics, which renamed itself in November 2025 to reflect a strategic pivot toward Zcash. The company pursues its mission through two primary strategies: accumulating Zcash on its balance sheet as a digital-asset treasury and investing in privacy-enhancing technologies. Its flagship holding is Zcash, a cryptocurrency designed to offer enhanced privacy features, which the company frames as consistent with the broader cypherpunk ethos of self-sovereignty and resistance to surveillance.

Through its subsidiary Leap Therapeutics, the company also continues to develop biomarker-targeted antibody therapies for cancer, including the anti-DKK1 antibody sirexatamab (formerly DKN-01) for DKK1-high metastatic colorectal cancer. This dual structure — a crypto treasury and mining operation alongside a clinical-stage oncology program — is unusual and is a key reason investors follow the stock. Cypherpunk has also invested $5 million in the Zcash Open Development Lab (ZODL), the developer behind a widely used Zcash wallet, extending its influence across the Zcash ecosystem from mining to treasury holdings to software development.

Recent Developments Driving the Stock

The dominant catalyst over the past several months was the August 2026 launch of Cypherpunk Mining. Through a $33.33 million equity-based transaction with Winklevoss Capital, the company acquired a fleet of Bitmain Z15 Pro machines deploying approximately 4.2 GSol/s of Equihash hashrate across U.S. facilities — about 18% of total Zcash network hashrate and, by the company's description, the world's largest Zcash mining fleet. The purchase was funded by a pre-funded warrant for roughly 43.3 million shares, reflecting a per-share value of $0.77. Mining veteran Kevin Zhang joined as Head of Mining, and the operation generated 3,023.13 ZEC during its first two weeks, all added to the corporate treasury.

In September 2026 the company added Amanda Fabiano, a mining executive with experience at Nakamoto, TeraWulf, Galaxy, and Fidelity, to its board. Cantor Fitzgerald subsequently raised its price target on CYPH to $4.90 from $1.60, citing the mining expansion and treasury strategy. These developments were partially offset by a Nasdaq bid-price deficiency notice issued in July 2026, which gives the company until January 2027 to regain compliance with the $1.00 minimum bid-price requirement, with a reverse split under consideration. From what I see, the compliance timeline remains an important factor to monitor.

2026 Outlook and Key Factors to Watch

Several factors will shape CYPH's path through the remainder of 2026. First, the ZEC price remains the single most important driver of the company's net asset value and reported earnings, given that unrealized gains and losses on treasury holdings flow through the income statement. Second, investors should monitor the pace of Zcash accumulation toward the company's stated goal of holding 5% of total supply, alongside monthly mining production and any updates on hashrate share. Third, the Nasdaq compliance deadline in January 2027 means any capital-structure actions, including a potential reverse split, warrant close attention. Finally, the biotech subsidiary's plans for a Phase 3 sirexatamab trial represent a separate, longer-dated catalyst that could require significant capital. The company has acknowledged it may need to raise funds if ZEC does not recover, adding both dilution risk and financing uncertainty to the outlook. I'm watching this closely as the year progresses.

AI Tools in My Research Process

I often turn to Tickeron’s AI Daily Buy/Sell Signals when evaluating names like CYPH that move with crypto sentiment. The platform helps surface patterns across thousands of tickers and can highlight when automated systems are shifting their stance on a stock. It has become a useful addition to my workflow for keeping tabs on volatile holdings without having to monitor every signal manually.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CYPH

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


CYPH in downward trend: price dove below 50-day moving average on November 09, 2026

CYPH moved below its 50-day moving average on November 09, 2026 date and that indicates a change from an upward trend to a downward trend. In 45 of 50 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CYPH as a result. In 64 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.

The Moving Average Convergence Divergence Histogram (MACD) for CYPH turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 32 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.

The 10-day moving average for CYPH crossed bearishly below the 50-day moving average on November 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CYPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for CYPH entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +21.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where CYPH advanced for three days, in 216 of 243 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. CYPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.228) is normal, around the industry mean (2.423). P/E Ratio (4.500) is within average values for comparable stocks, (8.341). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.318). Dividend Yield (0.000) settles around the average of (0.274) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (15.906).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CYPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.

Notable companies

The most notable companies in this group are Ares Capital Corp (NASDAQ:ARCC), WisdomTree (NYSE:WT), AMTD Idea Group (NYSE:AMTD).

Industry description

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

Market Cap

The average market capitalization across the Investment Managers Industry is 8.92B. The market cap for tickers in the group ranges from 1.6 to 182.57B. BLK holds the highest valuation in this group at 182.57B. The lowest valued company is OXLCO at 1.6.

High and low price notable news

The average weekly price growth across all stocks in the Investment Managers Industry was -6%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was -7%. ICMB experienced the highest price growth at 66%, while OXSQ experienced the biggest fall at -32%.

Volume

The average weekly volume growth across all stocks in the Investment Managers Industry was 11%. For the same stocks of the Industry, the average monthly volume growth was -15% and the average quarterly volume growth was -12%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 65
P/E Growth Rating: 58
Price Growth Rating: 57
SMR Rating: 67
Profit Risk Rating: 81
Seasonality Score: 16 (-100 ... +100)
AI Screener 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in clinical stage immuno-oncology

Industry InvestmentManagers

Industry
Biotechnology
Address
47 Thorndike Street
Phone
+1 617 714-0360
Employees
6
Web
https://www.cypherpunk.com
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
SAP's U.S. shares fell from Monday's close of $233.83 to $221.99 by late Tuesday morning in New York, a -5.06% decline recorded during regular trading hours. The company-specific trigger was the announced exit of Chief Customer Officer Thomas Saueressig, an executive board member since 2019, who will leave at the end of March 2027 to become CEO of IONOS; the disclosure came before the U.S. open.
Different growth engines: MRVL is riding accelerating AI data-center demand for custom chips and networking, while QCOM remains heavily tied to a soft smartphone market. Momentum contrast: Marvell's data-center revenue guidance has strengthened, whereas Qualcomm's near-term outlook has been pressured by memory-supply constraints and shrinking handset volumes.
TMC fell from Monday's $2.11 close to $1.96 by 10:10 a.m. ET, a -7.11% decline that occurred entirely in the regular session after an early premarket gain faded. No verified news or fundamental catalyst found for the drop; the move is likely technical, extending the post-Q3 unwind that followed NOAA pushing its certification decision to mid-December, with the stock averaging a 4.0% daily swing and logging 11 sessions of 7%-or-larger moves in the last 60.
IonQ slid from Monday's close of $26.45 to $24.73 on Tuesday, a -6.50% move that unfolded during regular trading hours after modest premarket gains faded. The decline was sector-driven rather than company-specific: quantum and AI-adjacent speculative names extended a multi-session liquidation ahead of Nvidia's quarterly report, with unease over Nvidia's abrupt CEO transition keeping risk appetite weak.